Global Virtual Clinical Trials (VCTs) Market Size, Share & Trends Report Segmented by Study Design (Interventional, Observational, Expanded Access), Phase (I, II, III, IV), Indication (Oncology, CVD, Autoimmune), Component (Software, Services) Industry Analysis & Regional Forecast to 2030
The global virtual clinical trials market is set to witness a growth rate of ~6% in the next 5 years. Rising adoption of decentralized trial models, advancements in digital health technologies, COVID-19 pandemic impact, increasing focus on patient-centric trials, and advantages such as cost and time efficiency, are some of the key factors driving the virtual clinical trials market. To learn more about the research report, download a sample report.
Overview
Virtual Clinical Trials (VCTs) are research studies that leverage digital health technologies to conduct some, or all, study procedures remotely. In doing so, VCTs utilize telemedicine, mobile applications, wearable devices, and electronic health record data, and can achieve this in a way that allows patients to participate from the convenience of their home. VCTs provide many benefits like reducing, or even completely removing, the need for participants to go to in-person sites. These factors ultimately reduce costs, increase patient access to clinical trials, and provide a potential improvement in data collection efficiencies. VCTs are especially significant for organizations to access population diversity and maintain trial operations in the case of natural disasters or pandemic-related imperatives.
To learn more about this report, download the PDF brochure
Rising adoption of decentralized trial models to drive market growth
Growing adoption of decentralized trial models is contributing to the growth of the virtual clinical trials market. Decentralized trial models have enabled patients to participate from home by utilizing digital resources for data gathering, monitoring, and communication. Decentralizing reduces the need for physical sites and allows sponsors to reach and recruit a broader patient population. In addition, study sponsors can reduce operational costs, speeds timelines, and improve patient retention and compliance. Demand for virtual trials is growing as pharmaceutical companies continue to seek research approaches that are more efficient and more inclusive.
Rising use of eConsent and eCOA platforms – A key market trend
The increasing use of eConsent and eCOA (electronic Clinical Outcome Assessment) platforms is changing the perspective about virtual clinical trials, particularly with regard to patient onboarding and patient data collection process. The use of eConsent enhances participant understanding and compliance through multimedia content and remote signing, improving recruitment and retention. eCOA also promotes patient participation by allowing real-time patient reported outcomes and minimizing instances of errors and inaccuracies. eCOA platforms can support remote monitoring of medications, interventions, etc., and they can decrease sites burden. With a shift toward decentralized trials, adopting eConsent and eCOA platforms will be a necessary plan to develop and manage efficient, patient-centric trials.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global virtual clinical trials market is marked by the presence of established and emerging market players such as IQVIA, Parexel International (MA) Corporation, Medable Inc., ICON plc, Laboratory Corporation of America Holdings, Dassault Systèmes, Oracle, Science 37, Signant Health, and Clinical Ink; among others. Some of the key strategies adopted by market players include strategic partnerships & collaborations and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 – 2024 |
| Forecast Period | 2025 – 2030 |
| Growth Rate | 6% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Study Design, Phase, Indication, Component, End User |
| Regional Scope |
|
| Key Companies Mapped | IQVIA, Parexel International (MA) Corporation, Medable Inc., ICON plc, Laboratory Corporation of America Holdings, Dassault Systèmes, Oracle, Science 37, Signant Health, Clinical Ink, among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Virtual Clinical Trials Market Segmentation
This report by Medi-Tech Insights provides the size of the global virtual clinical trials market at the regional- and country-level from 2023 to 2030. The report further segments the market based on study design, phase, indication, component, and end user.
Market Size & Forecast (2023-2030), By Study Design, USD Million
- Interventional
- Observational
- Expanded Access
Market Size & Forecast (2023-2030), By Phase, USD Million
- Phase I
- Phase II
- Phase III
- Phase IV
Market Size & Forecast (2023-2030), By Indication, USD Million
- Oncology
- Cardiovascular Diseases
- CNS Disorders
- Infectious Diseases
- Metabolic Disorders
- Autoimmune/Inflammation
- Others
Market Size & Forecast (2023-2030), By Component, USD Million
- Software
- Services
Market Size & Forecast (2023-2030), By End User, USD Million
- Pharmaceutical and Biopharmaceutical Companies
- Medical Device Companies
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the virtual clinical trials market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the virtual clinical trials market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Virtual Clinical Trials Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising adoption of decentralized trial models
- Advancements in digital health technologies
- COVID-19 pandemic impact
- Increasing focus on patient-centric trials
- Advantages such as cost and time efficiency
- Restraints
- Regulatory and compliance uncertainty
- Data privacy and security concerns
- Digital divide and limited accessibility
- Technological integration challenges
- Opportunities
- Expansion in rare and chronic disease trials
- Growth in AI and analytics integration
- Emergence of hybrid trial models
- Increasing investment and collaborations
- Key Market Trends
- Rising use of eConsent and eCOA platforms
- Wider use of wearables and remote monitoring devices
- Unmet Market Needs
- Industry Speaks
- Drivers
- Market Dynamics
- Global Virtual Clinical Trials Market Size & Forecast (2023-2030), By Study Design, USD Million
- Introduction
- Interventional
- Observational
- Expanded Access
- Global Virtual Clinical Trials Market Size & Forecast (2023-2030), By Phase, USD Million
- Introduction
- Phase I
- Phase II
- Phase III
- Phase IV
- Global Virtual Clinical Trials Market Size & Forecast (2023-2030), By Indication, USD Million
- Introduction
- Oncology
- Cardiovascular Diseases
- CNS Disorders
- Infectious Diseases
- Metabolic Disorders
- Autoimmune/Inflammation
- Others
- Global Virtual Clinical Trials Market Size & Forecast (2023-2030), By Component, USD Million
- Introduction
- Software
- Services
- Global Virtual Clinical Trials Market Size & Forecast (2023-2030), By End User, USD Million
- Introduction
- Pharmaceutical and Biopharmaceutical Companies
- Medical Device Companies
- Others
- Global Virtual Clinical Trials Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Virtual Clinical Trials Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Study Design (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Component (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Canada
- Market Size & Forecast, By Study Design (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Component (USD Million)
- Market Size & Forecast, By End User (USD Million)
- US
- Europe Virtual Clinical Trials Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Study Design (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Component (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Germany
- Market Size & Forecast, By Study Design (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Component (USD Million)
- Market Size & Forecast, By End User (USD Million)
- France
- Market Size & Forecast, By Study Design (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Component (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Italy
- Market Size & Forecast, By Study Design (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Component (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Spain
- Market Size & Forecast, By Study Design (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Component (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe
- Market Size & Forecast, By Study Design (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Component (USD Million)
- Market Size & Forecast, By End User (USD Million)
- UK
- Asia Pacific (APAC) Virtual Clinical Trials Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Study Design (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Component (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Japan
- Market Size & Forecast, By Study Design (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Component (USD Million)
- Market Size & Forecast, By End User (USD Million)
- India
- Market Size & Forecast, By Study Design (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Component (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Study Design (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Component (USD Million)
- Market Size & Forecast, By End User (USD Million)
- China
- Latin America (LATAM) Virtual Clinical Trials Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Study Design (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Component (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Virtual Clinical Trials Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Study Design (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Component (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product and Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- IQVIA
- Parexel International (MA) Corporation
- Medable Inc.
- ICON plc
- Laboratory Corporation of America Holdings
- Dassault Systèmes
- Oracle
- Science 37
- Signant Health
- Clinical Ink
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Pharmaceutical and Biopharmaceutical Companies; Medical Device Companies; and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
Features of the Report
- Comprehensive Market Coverage
- Market Size and Forecast
- Geographic & Segment Deep Dives
- Strategic Insights & Competitive Landscape
- Timely & Updated Data
- Growth Indicators & Future Outlook
- Quick Turnaround on Queries
- Analyst Support
- Report Customization Available
- Reports in PDF & Excel
